JAMES REINHARD: Open Payments
NPI 1558689927 · CEDAR BLUFF, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 32 payments from 7 companies in 2025. Trend: 2023 $831 · 2024 $713 · 2025 $770
Food & beverage: $765Education: $5
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $312 |
| Alkermes, Inc. | 13 | $188 |
| Janssen Pharmaceuticals, Inc | 7 | $176 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: AUSTEDO XR, ARISTADA, UZEDY, INVEGA SUSTENNA, SPRAVATO, INGREZZA, VRAYLAR, COBENFY.
Industry payments across VA — which companies pay providers there.
